Cargando…
A Novel KRAS Antibody Highlights a Regulation Mechanism of Post-Translational Modifications of KRAS during Tumorigenesis
KRAS is a powerful oncogene responsible for the development of many cancers. Despite the great progress in understanding its function during the last decade, the study of KRAS expression, subcellular localization, and post-translational modifications remains technically challenging. Accordingly, man...
Autores principales: | Assi, Mohamad, Pirlot, Boris, Stroobant, Vincent, Thissen, Jean-Paul, Jacquemin, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504708/ https://www.ncbi.nlm.nih.gov/pubmed/32887255 http://dx.doi.org/10.3390/ijms21176361 |
Ejemplares similares
-
KRAS protein expression becomes progressively restricted during embryogenesis and in adulthood
por: Minati, Marie-Albane, et al.
Publicado: (2022) -
Past and Future Strategies to Inhibit Membrane Localization of the KRAS Oncogene
por: Haidar, Malak, et al.
Publicado: (2021) -
ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis
por: Wang, Lidong, et al.
Publicado: (2019) -
Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
por: Luo, Yongde, et al.
Publicado: (2021) -
Cancer Stemness in Apc- vs. Apc/KRAS-Driven Intestinal Tumorigenesis
por: Ghazvini, Mehrnaz, et al.
Publicado: (2013)